S-Ethylisothio urea, hydrobromide

CAS: 1071-37-0

Ref. 3D-FE23156

Informação sobre produto

• Nome: S-Ethylisothio urea, hydrobromide
• Sinónimos: 2-Ethyl-2-thiopseudourea hydrobromideCarbamimidothioic acid ethyl ester, hydrobromide2-Ethyl-2-thio-pseudourea monohydrobromide, (Ethylsulfanyl)(imino)methanaminium bromide, (Ethylsulfanyl)methanimidamide hydrobromide, 1-Ethylthiourea, 2-Ethylisothiourea hydrobromide, Carbamimidothioic acid, ethyl ester, hydrobromide (1:1), Carbamimidothioic acid, ethyl ester, monohydrobromide, Ethiron, Ethiron bromide, Ethyl Carbamimidothioate, Ethyl Carbamimidothioate Hydrobromide (1:1), Ethyl imidothiocarbamate hydrobromide, Ethylisothiourea hydrobromide, Etiron, Isothuron hydrobromide, Isothurone hydrobromide, Pseudourea, 2-ethyl-2-thio-, hydrobromide, Pseudourea, 2-ethyl-2-thio-, monohydrobromide, S-Ethyl isothiouronium bromide, S-Ethylisothiourea bromide, S-Ethylisothiourea hydrobromide, S-Ethylisothiouronium hydrobromide, S-Ethylisothiuronium bromide, S-Ethylthiuronium bromide, S-ethylthiouronium bromide, Wr 539
• CAS: 1071-37-0

Descrição

S-Ethylisothio urea, hydrobromide is a nitric oxide (NO) synthase inhibitor that prevents the conversion of arginine to NO. It has been shown to inhibit protein synthesis in cells, which may be due to its ability to inhibit guanylate cyclase and intracellular calcium concentrations. S-Ethylisothio urea, hydrobromide has been used in experimental models as an anti-inflammatory drug for the treatment of autoimmune diseases like rheumatoid arthritis. This compound also blocks the production of NO by inhibiting the oxygen transport system in the lungs, which is required for redox potential. S-Ethylisothio urea, hydrobromide is a cyclase inhibitor that prevents the conversion of dehydroascorbic acid to ascorbic acid. It can be used as an antioxidant by scavenging reactive oxygen species and preventing oxidative damage.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 185.09 g/mol
• Fórmula: C₃H₉BrN₂S
• Pureza: Min. 95%